{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:42:01Z","timestamp":1789785721820,"version":"4.0.1"},"reference-count":31,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2015]]},"DOI":"10.1536\/ihj.14-187","type":"journal-article","created":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T00:14:36Z","timestamp":1424736876000},"page":"174-179","source":"Crossref","is-referenced-by-count":7,"title":["Late Rejection Occurred in Recipients Who Experienced Acute Cellular Rejection Within the First Year After Heart Transplantation"],"prefix":"10.1536","volume":"56","author":[{"given":"Teruhiko","family":"Imamura","sequence":"first","affiliation":[{"name":"Department of Therapeutic Strategy for Heart Failure, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Kinugawa","sequence":"additional","affiliation":[{"name":"Department of Therapeutic Strategy for Heart Failure, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Nitta","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Fujino","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Inaba","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisataka","family":"Maki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Hatano","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Nawata","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunei","family":"Kyo","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Ono","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Nakatani T. Heart transplantation. Circ J 2009; 73: A55-60. (Review)","DOI":"10.1253\/circj.CJ-09-0340"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Stehlik J, Edwards LB, Kucheryavaya AY, <i>et al<\/i>. The Registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report--2012. J Heart Lung Transplant 2012; 31: 1052-64.","DOI":"10.1016\/j.healun.2012.08.002"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Imamura T, Kinugawa K, Kato N, <i>et al<\/i>. Successful treatment of hemodynamic compromise caused by antibody-mediated and cellular rejection in a recipient 12 years after heart transplantation. Int Heart J 2013; 54: 328-31.","DOI":"10.1536\/ihj.54.328"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Imamura T, Kinugawa K, Murasawa T, <i>et al<\/i>. Cardiac allograft vasculopathy can be distinguished from donor-transmitted coronary atherosclerosis by optical coherence tomography imaging in a heart transplantation recipient: double layered intimal thickness. Int Heart J 2014; 55: 178-80.","DOI":"10.1536\/ihj.13-279"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Imamura T, Kinugawa K, Ono M, <i>et al<\/i>. Everolimus-incorporated immunosuppressant strategy improves renal dysfunction while maintaining low rejection rates after heart transplantation in Japanese patients. Int Heart J 2013; 54: 222-7.","DOI":"10.1536\/ihj.54.222"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Rodriguez Cetina Biefer H, S\u00fcndermann SH, Emmert MY, <i>et al<\/i>. Surviving 20 years after heart transplantation: a success story. Ann Thorac Surg 2014; 97: 499-504.","DOI":"10.1016\/j.athoracsur.2013.08.040"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Galeone A, Kirsch M, Barreda E, <i>et al<\/i>. Clinical outcome and quality of life of patients surviving 20 years or longer after heart transplantation. Transpl Int 2014; 27: 576-82.","DOI":"10.1111\/tri.12298"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Cal\u00e9 R, Almeida M, Gon\u00e7alves P, <i>et al<\/i>. Complications of endomyocardial biopsy after heart transplantation: a lesser evil. Rev Port Cardiol 2012; 31: 159-62. (Portuguese)","DOI":"10.1016\/j.repc.2011.12.006"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Wong RC, Abrahams Z, Hanna M, <i>et al<\/i>. Tricuspid regurgitation after cardiac transplantation: an old problem revisited. J Heart Lung Transplant 2008; 27: 247-52. (Review)","DOI":"10.1016\/j.healun.2007.12.011"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Zhou B, Saito S, Nakazawa Y, <i>et al<\/i>. Existence of an immunoglobulin G component of naturally occurring HLA class I antibodies that are not directed against selfantigens in human serum. Tissue Antigens 2008; 72: 98-104.","DOI":"10.1111\/j.1399-0039.2008.01074.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Mehra MR, Crespo-Leiro MG, Dipchand A, <i>et al<\/i>. International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. J Heart Lung Transplant 2010; 29: 717-27.","DOI":"10.1016\/j.healun.2010.05.017"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Stewart S, Winters GL, Fishbein MC, <i>et al<\/i>. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005; 24: 1710-20.","DOI":"10.1016\/j.healun.2005.03.019"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Prendergast TW, Furukawa S, Beyer AJ 3rd, Browne BJ, Eisen HJ, Jeevanandam V. The role of gender in heart transplantation. Ann Thorac Surg 1998; 65: 88-94.","DOI":"10.1016\/S0003-4975(97)01105-3"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Foerster A, Abdelnoor M, Geiran O, <i>et al<\/i>. Morbidity risk factors in human cardiac transplantation. Histoincompatibility and protracted graft ischemia entail high risk of rejection and infection. Scand J Thorac Cardiovasc Surg 1992; 26: 169-76.","DOI":"10.3109\/14017439209099074"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Jalowiec A, Grady KL, White-Williams C. First-year clinical outcomes in gender-mismatched heart transplant recipients. J Cardiovasc Nurs 2012; 27: 519-27.","DOI":"10.1097\/JCN.0b013e31822ce6c9"},{"key":"16","unstructured":"16. Jarcho J, Naftel DC, Shroyer TW, <i>et al<\/i>. Influence of HLA mismatch on rejection after heart transplantation: a multiinstitutional study. The Cardiac Transplant Research Database Group. J Heart Lung Transplant 1994; 13: 583-95."},{"key":"17","unstructured":"17. Nishimura M. Surgical treatment for severe heart failure: recent progress in treatment strategy and its present status in Japan. Yonago Acta Med 2012; 55: 49-56."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kitamura S. Heart transplantation in Japan: a critical appraisal for the results and future prospects. Gen Thorac Cardiovasc Surg 2012; 60: 639-44. (Review)","DOI":"10.1007\/s11748-012-0110-7"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989; 261: 3561-6.","DOI":"10.1001\/jama.1989.03420240075030"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Potena L, Holweg CT, Chin C, <i>et al<\/i>. Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection. Transplantation 2006; 82: 398-405.","DOI":"10.1097\/01.tp.0000229039.87735.76"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Stypmann J, Engelen MA, Eckernkemper S, <i>et al<\/i>. Calcineurin inhibitor-free immunosuppression using everolimus (Certican) after heart transplantation: 2 years\u2019 follow-up from the University Hospital M\u00fcnster. Transplant Proc 2011; 43: 1847-52.","DOI":"10.1016\/j.transproceed.2010.12.062"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Budde K, Becker T, Arns W, <i>et al<\/i>. Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial. Lancet 2011; 377: 837-47.","DOI":"10.1016\/S0140-6736(10)62318-5"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Reinsmoen NL, Lai CH, Mirocha J, <i>et al<\/i>. Increased negative impact of donor HLA-specific together with non-HLA-specific antibodies on graft outcome. Transplantation 2014; 97: 595-601.","DOI":"10.1097\/01.TP.0000436927.08026.a8"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Frank R, Molina MR, Wald JW, Goldberg LR, Kamoun M, Lal P. Correlation of circulating donor-specific anti-HLA antibodies and presence of C4d in endomyocardial biopsy with heart allograft outcomes: a single-center, retrospective study. J Heart Lung Transplant 2013; 32: 410-7.","DOI":"10.1016\/j.healun.2012.12.005"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Loupy A, Cazes A, Guillemain R, <i>et al<\/i>. Very late heart transplant rejection is associated with microvascular injury, complement deposition and progression to cardiac allograft vasculopathy. Am J Transplant 2011; 11: 1478-87.","DOI":"10.1111\/j.1600-6143.2011.03563.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Ravichandran AK, Schilling JD, Novak E, Pfeifer J, Ewald GA, Joseph SM. Rituximab is associated with improved survival in cardiac allograft patients with antibody-mediated rejection: a single center review. Clin Transplant 2013; 27: 961-7.","DOI":"10.1111\/ctr.12277"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. S\u00f6derlund C, \u00d6hman J, Nilsson J, <i>et al<\/i>. Acute cellular rejection the first year after heart transplantation and its impact on survival: a single-centre retrospective study at Sk\u00e5ne University Hospital in Lund 1988-2010. Transpl Int 2014; 27: 482-92.","DOI":"10.1111\/tri.12284"},{"key":"28","unstructured":"28. Kubo SH, Naftel DC, Mills RM Jr, <i>et al<\/i>. Risk factors for late recurrent rejection after heart transplantation: a multiinstitutional, multivariable analysis. Cardiac Transplant Research Database Group. J Heart Lung Transplant 1995; 14: 409-18."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Cooper LT, Baughman KL, Feldman AM, <i>et al<\/i>. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 2007; 116: 2216-33.","DOI":"10.1161\/CIRCULATIONAHA.107.186093"},{"key":"30","unstructured":"30. De Geest S, Abraham I, Moons P, <i>et al<\/i>. Late acute rejection and subclinical noncompliance with cyclosporine therapy in heart transplant recipients. J Heart Lung Transplant 1998; 17: 854-63."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Ringewald JM, Gidding SS, Crawford SE, Backer CL, Mavroudis C, Pahl E. Nonadherence is associated with late rejection in pediatric heart transplant recipients. J Pediatr 2001; 139: 75-8.","DOI":"10.1067\/mpd.2001.115067"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T06:06:26Z","timestamp":1498197986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/56\/2\/56_14-187\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.14-187","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}